FOLFIRINOX-3 plus bevacizumab (bFOLFIRINOX3) in chemo-refractory metastatic colorectal cancer: a multicenter phase II trial
Authors
- Hélène Bellio
- Jean-Florian Guion
- Jean-David Fumet (ORCID: https://orcid.org/0000-0002-9444-941X)
- Nicolas Roussot (ORCID: https://orcid.org/0000-0002-6562-6827)
- Axelle Boudrant
- François Ghiringhelli (ORCID: https://orcid.org/0000-0002-5465-8305)
- Zoé Tharin
- Alice Hervieu
- Sylvie Zanetta (ORCID: https://orcid.org/0000-0003-2002-0255)
- Thomas Collot (ORCID: https://orcid.org/0000-0003-4805-7682)
- Audrey Hennequin (ORCID: https://orcid.org/0000-0001-8043-1836)
- Aurélie Bertaut (ORCID: https://orcid.org/0000-0002-7934-9509)
- Leila Bengrine
- Julie Vincent
Institutions
- Inserm (FR)
- Université de Bourgogne (FR)
- Centre Georges François Leclerc (FR)
- Hôpital Sainte-Périne (FR)